Commission Implementing Decision (EU) 2021/2148 of 3 December 2021 on the unresolved objections regarding terms and conditions of the authorisation of the biocidal product family Oxybio in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
124/2022 In force in the EEA
Yes Legal documents
Commission Implementing Decision (EU) 2021/2148 of 3 December 2021 on the unresolved objections regarding terms and conditions of the authorisation of the biocidal product family Oxybio in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council
Durchführungsbeschluss (EU) 2021/2148 der Kommission vom 3. Dezember 2021 hinsichtlich gemäß Artikel 36 der Verordnung (EU) Nr. 528/2012 des Europäischen Parlaments und des Rates übermittelter ungelöster Einwände gegen die Bedingungen der Zulassung der Biozidproduktfamilie Oxybio
History
30.04.2022
Adopted JCD confirmed entry into force date
30.04.2022
Compliance date in the EEA
29.04.2022
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
19.01.2022
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
03.12.2021
Adoption date in the EU
26.12.2021
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.